These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 15668727)

  • 1. Depression in Parkinson's disease is related to a genetic polymorphism of the cannabinoid receptor gene (CNR1).
    Barrero FJ; Ampuero I; Morales B; Vives F; de Dios Luna Del Castillo J; Hoenicka J; García Yébenes J
    Pharmacogenomics J; 2005; 5(2):135-41. PubMed ID: 15668727
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Allelic variation of serotonin transporter expression is associated with depression in Parkinson's disease.
    Mössner R; Henneberg A; Schmitt A; Syagailo YV; Grässle M; Hennig T; Simantov R; Gerlach M; Riederer P; Lesch KP
    Mol Psychiatry; 2001 May; 6(3):350-2. PubMed ID: 11326308
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Visual hallucinations in Parkinson's disease are not influenced by polymorphisms of serotonin 5-HT2A receptor and transporter genes.
    Kiferle L; Ceravolo R; Petrozzi L; Rossi C; Frosini D; Rocchi A; Siciliano G; Bonuccelli U; Murri L
    Neurosci Lett; 2007 Jul; 422(3):228-31. PubMed ID: 17614196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Depressive illness in Parkinson's disease--indication of a more advanced and widespread neurodegenerative process?
    Pålhagen SE; Carlsson M; Curman E; Wålinder J; Granérus AK
    Acta Neurol Scand; 2008 May; 117(5):295-304. PubMed ID: 18279483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Depression in Parkinson's disease. Part 1: epidemiology, signs and symptoms, pathophysiology and diagnosis].
    Storch A; Ebersbach G; Fuchs G; Jost WH; Odin P; Reifschneider G; Bauer M
    Fortschr Neurol Psychiatr; 2008 Dec; 76(12):715-24. PubMed ID: 19012223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A CD14 monocyte receptor polymorphism and genetic susceptibility to Parkinson's disease for females.
    Lin JJ; Chen CH; Yueh KC; Chang CY; Lin SZ
    Parkinsonism Relat Disord; 2006 Jan; 12(1):9-13. PubMed ID: 16337421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The cannabinoid receptor 1 gene (CNR1) and multiple sclerosis: an association study in two case-control groups from Spain.
    Ramil E; Sánchez AJ; González-Pérez P; Rodríguez-Antigüedad A; Gómez-Lozano N; Ortiz P; Arroyo R; De las Heras V; Vilches C; García-Merino A
    Mult Scler; 2010 Feb; 16(2):139-46. PubMed ID: 20007426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brain-derived neurotrophic factor G196A polymorphism and clinical features in Parkinson's disease.
    Gao L; Díaz-Corrales FJ; Carrillo F; Díaz-Martín J; Caceres-Redondo MT; Carballo M; Palomino A; López-Barneo J; Mir P
    Acta Neurol Scand; 2010 Jul; 122(1):41-5. PubMed ID: 20085561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic polymorphisms in Parkinson disease subjects with and without hallucinations: an analysis of the cholecystokinin system.
    Goldman JG; Goetz CG; Berry-Kravis E; Leurgans S; Zhou L
    Arch Neurol; 2004 Aug; 61(8):1280-4. PubMed ID: 15313848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of tau gene polymorphism with Parkinson's disease.
    Zappia M; Annesi G; Nicoletti G; Serra P; Arabia G; Pugliese P; Messina D; Caracciolo M; Romeo N; Annesi F; Pasqua AA; Spadafora P; Civitelli D; Romeo N; Epifanio A; Morgante L; Quattrone A
    Neurol Sci; 2003 Oct; 24(3):223-4. PubMed ID: 14600827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A frequent polymorphism in the coding exon of the human cannabinoid receptor (CNR1) gene.
    Gadzicki D; Müller-Vahl K; Stuhrmann M
    Mol Cell Probes; 1999 Aug; 13(4):321-3. PubMed ID: 10441206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-10 (IL10) and tumor necrosis factor alpha (TNF) gene polymorphisms in Parkinson's disease patients.
    Bialecka M; Klodowska-Duda G; Kurzawski M; Slawek J; Gorzkowska A; Opala G; Bialecki P; Sagan L; Droździk M
    Parkinsonism Relat Disord; 2008 Dec; 14(8):636-40. PubMed ID: 18362084
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association study of sporadic Parkinson's disease genetic risk factors in patients from Russia by APEX technology.
    Shadrina M; Nikopensius T; Slominsky P; Illarioshkin S; Bagyeva G; Markova E; Ivanova-Smolenskaia I; Kurg A; Limborska S; Metspalu A
    Neurosci Lett; 2006 Sep; 405(3):212-6. PubMed ID: 16876316
    [TBL] [Abstract][Full Text] [Related]  

  • 14. No association of CNR1 gene variations with susceptibility to schizophrenia.
    Seifert J; Ossege S; Emrich HM; Schneider U; Stuhrmann M
    Neurosci Lett; 2007 Oct; 426(1):29-33. PubMed ID: 17881126
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mortality in Parkinson's disease and its association with dementia and depression.
    Hughes TA; Ross HF; Mindham RH; Spokes EG
    Acta Neurol Scand; 2004 Aug; 110(2):118-23. PubMed ID: 15242420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of association between polymorphic microsatellites of the VMAT2 gene and Parkinson's disease in Japan.
    Kariya S; Hirano M; Takahashi N; Furiya Y; Ueno S
    J Neurol Sci; 2005 May; 232(1-2):91-4. PubMed ID: 15850588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The CNR1 gene as a pharmacogenetic factor for antipsychotics rather than a susceptibility gene for schizophrenia.
    Hamdani N; Tabeze JP; Ramoz N; Ades J; Hamon M; Sarfati Y; Boni C; Gorwood P
    Eur Neuropsychopharmacol; 2008 Jan; 18(1):34-40. PubMed ID: 17669634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of a promoter polymorphism on the transcription of nitric oxide synthase 1 and its relevance to Parkinson's disease.
    Rife T; Rasoul B; Pullen N; Mitchell D; Grathwol K; Kurth J
    J Neurosci Res; 2009 Aug; 87(10):2319-25. PubMed ID: 19326438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Case-control study of estrogen receptor gene polymorphisms in Parkinson's disease.
    Maraganore DM; Farrer MJ; McDonnell SK; Elbaz A; Schaid DJ; Hardy JA; Rocca WA
    Mov Disord; 2002 May; 17(3):509-12. PubMed ID: 12112198
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The EcoR V polymorphism of human monoamine oxidase A is not associated with idiopathic Parkinson's disease in a Shanghai Han population].
    Xie H; Wang X; Hao Y; Tang G; Xu L; Wu Q; Chen L; Ren D
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2002 Aug; 19(4):329-31. PubMed ID: 12170473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.